ARTICLE | Distillery Therapeutics
Cancer
January 29, 2019 1:53 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting IRAK1 or its activator PIN1 could help treat radiotherapy-resistant, p53-mutant head and neck cancers and other cancers. In patients w...